Business Wire

NTT-DATA

26.6.2024 14:01:30 CEST | Business Wire | Press release

Share
NTT DATA and Zebra Technologies Drive Global Private 5G Adoption with Device as a Service Collaboration

NTT DATA, a global leader in IT infrastructure and services, today announced a strategic partnership with Zebra Technologies, a leader in digital solutions, to accelerate innovation in the 5G device ecosystem, laying the foundation for widespread adoption across industries.

Under this multi-year agreement, NTT DATA and Zebra Technologies will co-innovate to drive the adoption of 5G devices, which is essential for Private 5G adoption. Together, the two companies will enable intelligent asset tracking that allows for real-time monitoring and management of assets in industrial and enterprise deployments, ensuring enhanced visibility, efficiencies, and security capabilities critical to Industry 4.0 supply chain management.

One critical barrier to Private 5G adoption has been the availability of 5G devices for enterprises. This partnership will bridge this gap for connected devices in the enterprise Private 5G market, which Omdia estimates will grow 35% globally over the next four years, reaching nearly $10 billion by 2028.

Empowering the Private 5G Device Landscape

The agreement establishes Zebra Technologies as a strategic partner within NTT DATA’s Device as a Service practice, making it easier for customers to access, upgrade, and simplify 5G device lifecycle management and support.

Available globally, customers will benefit from continual modernization of device deployments and the ability to harness new connectivity solutions with a leading suite of Wi-Fi, Private LTE, and Private 5G compatible devices.

This news follows NTT DATA’s recent collaboration with Qualcomm, aimed to accelerate the evolution of the 5G device ecosystem. With enterprises accelerating digital transformation, more connectivity is needed to support Industry 4.0 applications and the adoption of AI at the edge.

By leveraging NTT DATA’s Private 5G leadership and Zebra Technologies' expertise in intelligent data integration, asset management, and frontline coordination, the two companies aim to make the low latency and high-security features of Private 5G enabled devices easily accessible to frontline workers in the automotive, manufacturing, healthcare, and logistics industries.

“In our relentless pursuit to drive Private 5G and Edge AI adoption within the enterprises, we’re thrilled to join forces with Zebra Technologies globally,” said Shahid Ahmed, Group Executive Vice President, Edge Services at NTT DATA. “This alliance underscores our dedication to empowering enterprises with transformative capabilities that propel edge and Private 5G use cases and data-driven experiences.”

“Our partnership with NTT DATA underscores our commitment to bring customers the latest innovations powered by Wi-Fi, Private LTE, and Private 5G networks,” said Julie Johnson, Senior Vice President and General Manager of Enterprise Mobile Computing at Zebra Technologies. “We’re excited to leverage the global scale of NTT DATA’s capabilities to benefit our customers and be a vital part of a growing 5G device ecosystem, ensuring businesses can thrive in today’s rapidly evolving landscape.”

Elevating Network Deployment

NTT DATA is deploying a Private 5G network throughout Hyster-Yale Group’s manufacturing operations. Hyster- Yale Group is also leveraging NTT DATA’s Device as a Service to gain visibility into assets and materials and improve communications within its facilities. This network will work with Zebra Technologies’, handheld mobile computers and tablets to track assets and materials as they enter and exit manufacturing sites, providing critical business intelligence, while also seamlessly connecting engineers, onsite teams, production lines, and materials storage locations. All of this comes together through a cost-effective deployment at scale efficiently managed through NTT DATA’s Device as a Service practice.

“Adding Zebra devices to our Store Front has allowed us to procure units through our Device as a Service program with NTT DATA, offering much more SKU customization within a standard device set,” said Pierluigi Mastroddi, Director of IT Infrastructure Services at Hyster-Yale Group.

Benefits of Device as a Services Model

NTT DATA’s Device as a Service offers customers a comprehensive turnkey solution for managing the entire device lifecycle. It provides expert planning, procurement, configuration, deployment, ongoing support, analytics, repair management, and device retirement, all under the stewardship of a trusted partner. This allows customers to use a cost-effective per-user, per-month program model to consume technology products on a pay-per-user subscription basis instead of purchasing/owning the equipment.

About NTT DATA

NTT DATA is a $30+ billion trusted global innovator of business and technology services. We serve 75% of the Fortune Global 100 and are committed to helping clients innovate, optimize, and transform for long-term success. We invest over $3.6 billion each year in R&D to help organizations and society move confidently and sustainably into the digital future. As a Global Top Employer, we have diverse experts in more than 50 countries and a robust partner ecosystem of established and start-up companies. Our services include business and technology consulting, data and artificial intelligence, industry solutions, as well as the development, implementation and management of applications, infrastructure, and connectivity. We are also one of the leading providers of digital and AI infrastructure in the world. NTT DATA is part of NTT Group and headquartered in Tokyo. Visit us at nttdata.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240625541170/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 10:22:00 CET | Press release

Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh

Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release

- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur

Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release

Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i

Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release

Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up

Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release

Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye